BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 25019302)

  • 21. Efficient production of erythroid, megakaryocytic and myeloid cells, using single cell-derived iPSC colony differentiation.
    Hansen M; Varga E; Aarts C; Wust T; Kuijpers T; von Lindern M; van den Akker E
    Stem Cell Res; 2018 May; 29():232-244. PubMed ID: 29751281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptome Profiling Reveals Degree of Variability in Induced Pluripotent Stem Cell Lines: Impact for Human Disease Modeling.
    Schuster J; Halvardson J; Pilar Lorenzo L; Ameur A; Sobol M; Raykova D; Annerén G; Feuk L; Dahl N
    Cell Reprogram; 2015 Oct; 17(5):327-37. PubMed ID: 26348590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parallel assessment of globin lentiviral transfer in induced pluripotent stem cells and adult hematopoietic stem cells derived from the same transplanted β-thalassemia patient.
    Tubsuwan A; Abed S; Deichmann A; Kardel MD; Bartholomä C; Cheung A; Negre O; Kadri Z; Fucharoen S; von Kalle C; Payen E; Chrétien S; Schmidt M; Eaves CJ; Leboulch P; Maouche-Chrétien L
    Stem Cells; 2013 Sep; 31(9):1785-94. PubMed ID: 23712774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Integrating and Non-Integrating Reprogramming Methods on Copy Number Variation and Genomic Stability of Human Induced Pluripotent Stem Cells.
    Kang X; Yu Q; Huang Y; Song B; Chen Y; Gao X; He W; Sun X; Fan Y
    PLoS One; 2015; 10(7):e0131128. PubMed ID: 26131765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic Variation between Human Induced Pluripotent Stem Cell Lines Is an Indicator of Differentiation Capacity.
    Nishizawa M; Chonabayashi K; Nomura M; Tanaka A; Nakamura M; Inagaki A; Nishikawa M; Takei I; Oishi A; Tanabe K; Ohnuki M; Yokota H; Koyanagi-Aoi M; Okita K; Watanabe A; Takaori-Kondo A; Yamanaka S; Yoshida Y
    Cell Stem Cell; 2016 Sep; 19(3):341-54. PubMed ID: 27476965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deciphering the Proteome Dynamics during Development of Neurons Derived from Induced Pluripotent Stem Cells.
    Varderidou-Minasian S; Verheijen BM; Schätzle P; Hoogenraad CC; Pasterkamp RJ; Altelaar M
    J Proteome Res; 2020 Jun; 19(6):2391-2403. PubMed ID: 32357013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential sensitivity to JAK inhibitory drugs by isogenic human erythroblasts and hematopoietic progenitors generated from patient-specific induced pluripotent stem cells.
    Ye Z; Liu CF; Lanikova L; Dowey SN; He C; Huang X; Brodsky RA; Spivak JL; Prchal JT; Cheng L
    Stem Cells; 2014 Jan; 32(1):269-78. PubMed ID: 24105986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of human donor cell source on differentiation and function of cardiac induced pluripotent stem cells.
    Sanchez-Freire V; Lee AS; Hu S; Abilez OJ; Liang P; Lan F; Huber BC; Ong SG; Hong WX; Huang M; Wu JC
    J Am Coll Cardiol; 2014 Aug; 64(5):436-48. PubMed ID: 25082575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mesenchymal stem cells derived from human induced pluripotent stem cells retain adequate osteogenicity and chondrogenicity but less adipogenicity.
    Kang R; Zhou Y; Tan S; Zhou G; Aagaard L; Xie L; Bünger C; Bolund L; Luo Y
    Stem Cell Res Ther; 2015 Aug; 6(1):144. PubMed ID: 26282538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a protein marker panel for characterization of human induced pluripotent stem cells (hiPSCs) using global quantitative proteome analysis.
    Pripuzova NS; Getie-Kebtie M; Grunseich C; Sweeney C; Malech H; Alterman MA
    Stem Cell Res; 2015 May; 14(3):323-38. PubMed ID: 25840413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid and deep profiling of human induced pluripotent stem cell proteome by one-shot NanoLC-MS/MS analysis with meter-scale monolithic silica columns.
    Yamana R; Iwasaki M; Wakabayashi M; Nakagawa M; Yamanaka S; Ishihama Y
    J Proteome Res; 2013 Jan; 12(1):214-21. PubMed ID: 23210603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reliable generation of induced pluripotent stem cells from human lymphoblastoid cell lines.
    Barrett R; Ornelas L; Yeager N; Mandefro B; Sahabian A; Lenaeus L; Targan SR; Svendsen CN; Sareen D
    Stem Cells Transl Med; 2014 Dec; 3(12):1429-34. PubMed ID: 25298370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic Variability Overrides the Impact of Parental Cell Type and Determines iPSC Differentiation Potential.
    Kyttälä A; Moraghebi R; Valensisi C; Kettunen J; Andrus C; Pasumarthy KK; Nakanishi M; Nishimura K; Ohtaka M; Weltner J; Van Handel B; Parkkonen O; Sinisalo J; Jalanko A; Hawkins RD; Woods NB; Otonkoski T; Trokovic R
    Stem Cell Reports; 2016 Feb; 6(2):200-12. PubMed ID: 26777058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteomics in the World of Induced Pluripotent Stem Cells.
    Lindoso RS; Kasai-Brunswick TH; Monnerat Cahli G; Collino F; Bastos Carvalho A; Campos de Carvalho AC; Vieyra A
    Cells; 2019 Jul; 8(7):. PubMed ID: 31336746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mapping Human Pluripotent Stem Cell-derived Erythroid Differentiation by Single-cell Transcriptome Analysis.
    Xin Z; Zhang W; Gong S; Zhu J; Li Y; Zhang Z; Fang X
    Genomics Proteomics Bioinformatics; 2021 Jun; 19(3):358-376. PubMed ID: 34284135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Production of Gene-Corrected Adult Beta Globin Protein in Human Erythrocytes Differentiated from Patient iPSCs After Genome Editing of the Sickle Point Mutation.
    Huang X; Wang Y; Yan W; Smith C; Ye Z; Wang J; Gao Y; Mendelsohn L; Cheng L
    Stem Cells; 2015 May; 33(5):1470-9. PubMed ID: 25702619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differentiation of human pluripotent stem cells to retinal pigmented epithelium in defined conditions using purified extracellular matrix proteins.
    Rowland TJ; Blaschke AJ; Buchholz DE; Hikita ST; Johnson LV; Clegg DO
    J Tissue Eng Regen Med; 2013 Aug; 7(8):642-53. PubMed ID: 22514096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of functional mesenchymal stem cells from different induced pluripotent stem cell lines.
    Hynes K; Menicanin D; Mrozik K; Gronthos S; Bartold PM
    Stem Cells Dev; 2014 May; 23(10):1084-96. PubMed ID: 24367908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Introduction to Erythropoiesis Approaches.
    Lloyd JA
    Methods Mol Biol; 2018; 1698():1-10. PubMed ID: 29076081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multilineage differentiation potential of hematoendothelial progenitors derived from human induced pluripotent stem cells.
    Netsrithong R; Suwanpitak S; Boonkaew B; Trakarnsanga K; Chang LJ; Tipgomut C; Vatanashevanopakorn C; Pattanapanyasat K; Wattanapanitch M
    Stem Cell Res Ther; 2020 Nov; 11(1):481. PubMed ID: 33176890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.